Bristol-Myers Squibb Company
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $1.01B | $4.46B | $1.57B | $2.00B | $2.56B | $1.96B | $3.71B | $3.10B |
| Depreciation & Amortization | $789.0M | $382.0M | $376.0M | $467.0M | $763.0M | $681.0M | $628.0M | $607.0M |
| Depreciation | $682.0M | $448.0M | $500.0M | $543.0M | $453.0M | $382.0M | $448.0M | $473.0M |
| Amortization | $190.0M | $178.0M | $183.0M | $286.0M | $858.0M | $607.0M | $353.0M | $271.0M |
| Stock-Based Compensation | $199.0M | $205.0M | $235.0M | $213.0M | $191.0M | $154.0M | $161.0M | $193.0M |
| Net Cash from Operating Activities | $5.28B | $3.06B | $2.11B | $3.15B | $3.55B | $6.94B | $4.84B | $4.49B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.06B | $1.22B | $820.0M | $526.0M | $537.0M | $548.0M | $367.0M | $424.0M |
| Business Acquisitions | $726.0M | $359.0M | $1.11B | $219.0M | — | $7.53B | $360.0M | $829.0M |
| Net Cash from Investing Activities | $-66.0M | $1.48B | $-1.57B | $1.22B | $-572.0M | $-6.73B | $-1.44B | $-3.81B |
| Financing Activities | ||||||||
| Dividends Paid | $2.58B | $2.55B | $2.48B | $2.40B | $2.31B | $2.29B | $2.25B | $2.20B |
| Stock Repurchases | $2.47B | $231.0M | — | — | $433.0M | $2.40B | $1.22B | $576.0M |
| Net Cash from Financing Activities | $-4.08B | $-2.65B | $-3.62B | $-2.44B | $-1.07B | $-4.33B | $-2.66B | $-3.34B |
| Net Change in Cash | $1.18B | $1.85B | $-3.19B | $1.99B | $1.93B | $-4.12B | $743.0M | $-2.65B |
| Free Cash Flow | $4.22B | $1.84B | $1.29B | $2.62B | $3.01B | $6.39B | $4.47B | $4.07B |